Currently holds positions in Pacira Biosciences Inc, Chiasma Inc and Amarin Corporation PLC
Position | Company | Period |
---|---|---|
Chairman of the Board, Chief Executive Officer | Pacira Biosciences Inc | Oct. 20, 2015 - |
Independent Chairman of the Board | Chiasma Inc | Jan. 1, 2014 - |
Non-Executive Independent Director | Amarin Corporation PLC | Dec. 10, 2012 - |
President, Chief Executive Officer, Director | Pacira Biosciences Inc | Nov. 1, 2007 - Oct. 20, 2015 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-06-08 | 2022-06-08 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
501
-0.4%
61.9631,042 USD |
501 -0.4% | 61.96 | 31,042 USD | |
2022-06-08 | 2022-06-08 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
1,282
-0.9%
61.3178,599 USD |
1,282 -0.9% | 61.31 | 78,599 USD | |
2022-06-08 | 2022-06-08 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
5,006
-3.4%
60.33302,012 USD |
5,006 -3.4% | 60.33 | 302,012 USD | |
2022-06-08 | 2022-06-08 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
7,039
-4.5%
59.10416,005 USD |
7,039 -4.5% | 59.10 | 416,005 USD | |
2022-06-08 | 2022-06-06 |
Pacira Biosciences Inc
(PCRX)
|
S Sale |
11,965
-7.1%
61.37734,340 USD |
11,965 -7.1% | 61.37 | 734,340 USD | |
2021-06-08 | 2021-06-04 |
Pacira Biosciences Inc
(PCRX)
|
S Sale |
14,905
-19.6%
61.04909,756 USD |
14,905 -19.6% | 61.04 | 909,756 USD | |
2021-06-07 | 2021-06-04 |
Amarin Corporation PLC
(AMRN)
|
B Purchase |
10,000
+33.3%
4.5445,350 USD |
10,000 +33.3% | 4.54 | 45,350 USD | |
2021-06-07 | 2021-06-03 |
Amarin Corporation PLC
(AMRN)
|
B Purchase |
5,000
+20.0%
4.6223,115 USD |
5,000 +20.0% | 4.62 | 23,115 USD | |
2021-05-13 | 2021-05-12 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
3,611
-4.5%
62.41225,363 USD |
3,611 -4.5% | 62.41 | 225,363 USD | |
2021-05-13 | 2021-05-12 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
14,669
-15.5%
62.08910,652 USD |
14,669 -15.5% | 62.08 | 910,652 USD | |
2021-05-13 | 2021-05-12 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
2,970
-3.1%
60.76180,457 USD |
2,970 -3.1% | 60.76 | 180,457 USD | |
2021-05-13 | 2021-05-11 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
7,932
-9.4%
61.19485,359 USD |
7,932 -9.4% | 61.19 | 485,359 USD | |
2021-05-13 | 2021-05-11 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
13,318
-13.7%
60.78809,468 USD |
13,318 -13.7% | 60.78 | 809,468 USD | |
2021-02-04 | 2021-02-03 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
14,350
-15.9%
71.421,024,877 USD |
14,350 -15.9% | 71.42 | 1,024,877 USD | |
2021-02-04 | 2021-02-03 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
6,900
-7.1%
70.78488,382 USD |
6,900 -7.1% | 70.78 | 488,382 USD | |
2021-02-04 | 2021-02-02 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
4,100
-5.1%
70.20287,820 USD |
4,100 -5.1% | 70.20 | 287,820 USD | |
2021-02-04 | 2021-02-02 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
14,250
-15.1%
69.38988,665 USD |
14,250 -15.1% | 69.38 | 988,665 USD | |
2021-02-04 | 2021-02-02 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
2,900
-3.0%
68.41198,389 USD |
2,900 -3.0% | 68.41 | 198,389 USD | |
2020-12-02 | 2020-11-30 |
Amarin Corporation PLC
(AMRN)
|
B Purchase |
25,000
+inf%
4.86121,518 USD |
25,000 +inf% | 4.86 | 121,518 USD | |
2020-12-01 | 2020-11-30 |
Chiasma Inc
(CHMA)
|
B Purchase |
25,000
+inf%
4.27106,858 USD |
25,000 +inf% | 4.27 | 106,858 USD | |
2020-10-16 | 2020-10-16 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
30,000
-14.8%
55.561,666,800 USD |
30,000 -14.8% | 55.56 | 1,666,800 USD | |
2020-10-16 | 2020-10-15 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
30,000
-14.8%
55.001,650,000 USD |
30,000 -14.8% | 55.00 | 1,650,000 USD | |
2020-10-16 | 2020-10-14 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
30,000
-14.8%
55.531,665,900 USD |
30,000 -14.8% | 55.53 | 1,665,900 USD | |
2020-08-19 | 2020-08-17 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
3,217
-1.8%
62.34200,548 USD |
3,217 -1.8% | 62.34 | 200,548 USD | |
2020-08-19 | 2020-08-17 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
11,783
-6.3%
61.79728,072 USD |
11,783 -6.3% | 61.79 | 728,072 USD | |
2020-07-17 | 2020-07-15 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
12,000
-6.0%
56.88682,560 USD |
12,000 -6.0% | 56.88 | 682,560 USD | |
2020-06-08 | 2020-06-08 |
Pacira Biosciences Inc
(PCRX)
|
S Sale |
1,721
-1.0%
48.4983,451 USD |
1,721 -1.0% | 48.49 | 83,451 USD | |
2020-06-08 | 2020-06-08 |
Pacira Biosciences Inc
(PCRX)
|
S Sale |
15,390
-8.4%
48.08739,951 USD |
15,390 -8.4% | 48.08 | 739,951 USD | |
2020-06-08 | 2020-06-04 |
Pacira Biosciences Inc
(PCRX)
|
S Sale |
14,314
-7.2%
46.33663,182 USD |
14,314 -7.2% | 46.33 | 663,182 USD | |
2020-01-17 | 2020-01-15 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
1,975
-62.0%
43.4885,873 USD |
1,975 -62.0% | 43.48 | 85,873 USD | |
2020-01-17 | 2020-01-15 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
23,025
-87.9%
42.61981,095 USD |
23,025 -87.9% | 42.61 | 981,095 USD | |
2019-07-12 | 2019-07-11 |
Amarin Corporation PLC
(AMRN)
|
PS Planned sale |
51,991
-100.0%
22.281,158,354 USD |
51,991 -100.0% | 22.28 | 1,158,354 USD | |
2019-07-10 | 2019-07-08 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
700
-0.4%
43.4230,394 USD |
700 -0.4% | 43.42 | 30,394 USD | |
2019-07-10 | 2019-07-08 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
12,415
-7.3%
42.85531,983 USD |
12,415 -7.3% | 42.85 | 531,983 USD | |
2019-06-06 | 2019-06-04 |
Pacira Biosciences Inc
(PCRX)
|
PS Planned sale |
12,385
-9.2%
42.91531,440 USD |
12,385 -9.2% | 42.91 | 531,440 USD | |
2019-05-31 | 2019-05-29 |
Amarin Corporation PLC
(AMRN)
|
PS Planned sale |
33,799
-100.0%
18.45623,534 USD |
33,799 -100.0% | 18.45 | 623,534 USD | |
2019-05-21 | 2019-05-17 |
Amarin Corporation PLC
(AMRN)
|
PS Planned sale |
13,174
-100.0%
18.00237,139 USD |
13,174 -100.0% | 18.00 | 237,139 USD | |
2019-01-11 | 2019-01-10 |
Amarin Corporation PLC
(AMRN)
|
PS Planned sale |
98,572
-100.0%
18.001,774,296 USD |
98,572 -100.0% | 18.00 | 1,774,296 USD | |
2019-01-11 | 2019-01-10 |
Amarin Corporation PLC
(AMRN)
|
PS Planned sale |
26,932
-100.0%
18.00484,776 USD |
26,932 -100.0% | 18.00 | 484,776 USD | |
2017-06-07 | 2017-06-05 |
Pacira Biosciences Inc
(PCRX)
|
S Sale |
4,311
-6.7%
43.32186,757 USD |
4,311 -6.7% | 43.32 | 186,757 USD | |
2004-10-05 | 2004-10-04 |
Bioclinica Inc
(BIOC)
|
PS Planned sale |
100
-0.1%
5.00500 USD |
100 -0.1% | 5.00 | 500 USD | |
2004-07-06 | 2004-07-01 |
Medicines Co
(MDCO)
|
PS Planned sale |
2,000
-31.2%
30.2560,500 USD |
2,000 -31.2% | 30.25 | 60,500 USD | |
2004-07-06 | 2004-07-01 |
Medicines Co
(MDCO)
|
PS Planned sale |
1,500
-25.4%
30.3545,525 USD |
1,500 -25.4% | 30.35 | 45,525 USD | |
2004-07-06 | 2004-07-01 |
Medicines Co
(MDCO)
|
PS Planned sale |
100
-2.2%
30.373,037 USD |
100 -2.2% | 30.37 | 3,037 USD | |
2004-07-06 | 2004-07-01 |
Medicines Co
(MDCO)
|
PS Planned sale |
400
-8.3%
30.3612,144 USD |
400 -8.3% | 30.36 | 12,144 USD | |
2004-07-06 | 2004-07-01 |
Medicines Co
(MDCO)
|
PS Planned sale |
1,000
-18.5%
30.4630,460 USD |
1,000 -18.5% | 30.46 | 30,460 USD | |
2004-07-06 | 2004-07-01 |
Medicines Co
(MDCO)
|
PS Planned sale |
500
-10.2%
30.5315,265 USD |
500 -10.2% | 30.53 | 15,265 USD | |
2004-07-06 | 2004-07-01 |
Medicines Co
(MDCO)
|
PS Planned sale |
500
-10.2%
30.6615,330 USD |
500 -10.2% | 30.66 | 15,330 USD | |
2004-07-06 | 2004-07-01 |
Medicines Co
(MDCO)
|
PS Planned sale |
1,000
-18.5%
30.5030,500 USD |
1,000 -18.5% | 30.50 | 30,500 USD | |
2004-05-05 | 2004-05-03 |
Bioclinica Inc
(BIOC)
|
PS Planned sale |
4,250
-3.8%
5.8624,911 USD |
4,250 -3.8% | 5.86 | 24,911 USD | |
2004-05-05 | 2004-05-03 |
Bioclinica Inc
(BIOC)
|
PS Planned sale |
2,500
-100.0%
5.8614,653 USD |
2,500 -100.0% | 5.86 | 14,653 USD | |
2004-05-04 | 2004-05-03 |
Medicines Co
(MDCO)
|
PS Planned sale |
100
-2.2%
32.733,273 USD |
100 -2.2% | 32.73 | 3,273 USD | |
2004-05-04 | 2004-05-03 |
Medicines Co
(MDCO)
|
PS Planned sale |
400
-8.3%
32.8013,120 USD |
400 -8.3% | 32.80 | 13,120 USD | |
2004-05-04 | 2004-05-03 |
Medicines Co
(MDCO)
|
PS Planned sale |
500
-10.2%
32.6016,300 USD |
500 -10.2% | 32.60 | 16,300 USD | |
2004-05-04 | 2004-05-03 |
Medicines Co
(MDCO)
|
PS Planned sale |
500
-10.2%
32.4016,200 USD |
500 -10.2% | 32.40 | 16,200 USD | |
2004-05-04 | 2004-05-03 |
Medicines Co
(MDCO)
|
PS Planned sale |
500
-10.2%
32.5916,295 USD |
500 -10.2% | 32.59 | 16,295 USD | |
2004-05-04 | 2004-05-03 |
Medicines Co
(MDCO)
|
PS Planned sale |
500
-10.2%
32.4216,210 USD |
500 -10.2% | 32.42 | 16,210 USD | |
2004-05-04 | 2004-05-03 |
Medicines Co
(MDCO)
|
PS Planned sale |
1,000
-18.5%
32.7032,700 USD |
1,000 -18.5% | 32.70 | 32,700 USD | |
2004-05-04 | 2004-05-03 |
Medicines Co
(MDCO)
|
PS Planned sale |
500
-10.2%
32.3216,160 USD |
500 -10.2% | 32.32 | 16,160 USD | |
2004-05-04 | 2004-05-03 |
Medicines Co
(MDCO)
|
PS Planned sale |
500
-10.2%
32.4316,215 USD |
500 -10.2% | 32.43 | 16,215 USD | |
2004-05-04 | 2004-05-03 |
Medicines Co
(MDCO)
|
PS Planned sale |
2,000
-31.2%
32.5065,000 USD |
2,000 -31.2% | 32.50 | 65,000 USD | |
2004-05-04 | 2004-05-03 |
Medicines Co
(MDCO)
|
PS Planned sale |
500
-10.2%
32.5216,260 USD |
500 -10.2% | 32.52 | 16,260 USD |